Eric Lefkofsky’s ‘Unicorn’ Tempus Receives $80 Million in Additional Funding

Eric Lefkofsky’s ‘Unicorn’ Tempus Receives $80 Million in Additional Funding

- in News
Comments Off on Eric Lefkofsky’s ‘Unicorn’ Tempus Receives $80 Million in Additional Funding

Image result for Eric Lefkofsky's 'Unicorn' Tempus Receives $80 Million in Additional Funding

The health tech company Tempus, led by CEO Eric Lefkofsky, has joined the exclusive group of Chicago startups that have “unicorn” status as an investment. The company recently received an investment from new and existing investors that providing the company with $80 million in funding. To date, the Chicago based company has accepted around $210 million in funding which leaves Tempus’ with a current value of around $1.1 billion.

Founded in 2014, Tempus aims to change the health care industry by making cancer care more efficient, effective and personalized to the patient using data in a newly implemented way. Its goal is to collect the molecular data of cancer patients around the world in order to help discover similarities and that could eventually lead to better treatments and make the disease more preventable. Not only does Eric Lefkofsky’s Tempus aim to add new types of data to a patient’s record, they want to make existing types of records better by making handwritten notes digitized and searchable.

Tempus has relationships with various organizations and professionals in every part of health care from doctors to drug companies. They all have the common goal of wanting to treat cancer more effectively. These professional ties also include researchers that will use the data to try to find new medications to better target the disease.

This use of big data could save lives through personalized medicine and by using their genetic information to determine the best treatments and medicinal therapy for them. EricLefkofsky believes the entire medical industry is in the middle of a paradigm shift and Tempus is a part of it.

Tempus is part of the Company Lightbank, co-founded by Lefkofsky, that specializes in disruptive technology. Some of the notable investors involved in this round of funding are the Kinship Trust Co. and T. Rowe Price Associates.

Eric Lefkofsky is also known in Chicago and around the world for his impressive works of philanthropy. He and his wife Liz co-founded the Lefkofsky Foundation in 2006. The goal of the organization is to improve human life in their communities. They want to achieve this by focusing on education, human rights for women and the underserved, medical research, and cultural initiatives.

The Lefkofsky’s have donated respectable amounts of money and other resources to cancer-related organizations like the American Brain Tumor Association and the Sidney Kimmel Comprehensive Cancer Center operated by John Hopkins Medicine. They have also been involved and donated to various research efforts by prestigious universities in the United States.

The Lefkofsky Foundation also helps humanity outside of the country with initiatives like the Medical Missions for Children. The MMFC helps facilitate access to surgery for children with facial deformities in the country of Guatemala. In addition, Eric Lefkofsky is deeply involved in his community of Chicago and is serves on the boards of different Chicago based museums and other organizations.

About the author